BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 27142135)

  • 1. Asthma-COPD Overlap Syndrome (ACOS): Single disease entity or not? Could exhaled nitric oxide be a useful biomarker for the differentiation of ACOS, asthma and COPD?
    Karampitsakos T; Gourgoulianis KI
    Med Hypotheses; 2016 Jun; 91():20-23. PubMed ID: 27142135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD.
    Chen FJ; Huang XY; Liu YL; Lin GP; Xie CM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2385-2390. PubMed ID: 27713629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
    Deng DD; Zhou AY; Shuang QC; Chen P
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):98-101. PubMed ID: 28209039
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome.
    Guo Y; Hong C; Liu Y; Chen H; Huang X; Hong M
    Medicine (Baltimore); 2018 Jun; 97(23):e10857. PubMed ID: 29879019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
    Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
    J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating fractional exhaled nitric oxide (FeNO) in chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO): a scoping review protocol.
    Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
    BMJ Open; 2017 Dec; 7(12):e018954. PubMed ID: 29273668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations.
    Tamada T; Sugiura H; Takahashi T; Matsunaga K; Kimura K; Katsumata U; Takekoshi D; Kikuchi T; Ohta K; Ichinose M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2169-76. PubMed ID: 26491283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap.
    Takayama Y; Ohnishi H; Ogasawara F; Oyama K; Kubota T; Yokoyama A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2525-2532. PubMed ID: 30174422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma-COPD overlap syndrome (ACOS): A diagnostic challenge.
    Tho NV; Park HY; Nakano Y
    Respirology; 2016 Apr; 21(3):410-8. PubMed ID: 26450153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma-COPD overlap syndrome: recent advances in diagnostic criteria and prognostic significance.
    Sorino C; Scichilone N; D'Amato M; Patella V; DI Marco F
    Minerva Med; 2017 Jun; 108(3 Suppl 1):1-5. PubMed ID: 28862414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma-COPD overlap syndrome (ACOS) vs 'pure' COPD: a distinct phenotype?
    Caillaud D; Chanez P; Escamilla R; Burgel PR; Court-Fortune I; Nesme-Meyer P; Deslee G; Perez T; Paillasseur JL; Pinet C; Jebrak G; Roche N;
    Allergy; 2017 Jan; 72(1):137-145. PubMed ID: 27501862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
    Cosío BG; Pérez de Llano L; Lopez Viña A; Torrego A; Lopez-Campos JL; Soriano JB; Martinez Moragon E; Izquierdo JL; Bobolea I; Callejas J; Plaza V; Miravitlles M; Soler-Catalunya JJ;
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28461299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Fractional Exhaled Nitric Oxide in Elderly Patients with Asthma-chronic Obstructive Pulmonary Disease Overlap and Other Airway Inflammatory Diseases.
    Shi F; Qiu C; Yu J; Yang Y; Li B; Feng M; Zhang T; Liu W
    Iran J Allergy Asthma Immunol; 2018 Jun; 17(3):232-239. PubMed ID: 29908540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort.
    Cosio BG; Soriano JB; López-Campos JL; Calle-Rubio M; Soler-Cataluna JJ; de-Torres JP; Marín JM; Martínez-Gonzalez C; de Lucas P; Mir I; Peces-Barba G; Feu-Collado N; Solanes I; Alfageme I; Casanova C;
    Chest; 2016 Jan; 149(1):45-52. PubMed ID: 26291753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Belgian survey on the diagnosis of asthma-COPD overlap syndrome.
    Cataldo D; Corhay JL; Derom E; Louis R; Marchand E; Michils A; Ninane V; Peché R; Pilette C; Vincken W; Janssens W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():601-613. PubMed ID: 28243078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do we really need asthma-chronic obstructive pulmonary disease overlap syndrome?
    Cazzola M; Rogliani P
    J Allergy Clin Immunol; 2016 Oct; 138(4):977-983. PubMed ID: 27372569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional exhaled nitric oxide levels in asthma-COPD overlap syndrome: analysis of the National Health and Nutrition Examination Survey, 2007-2012.
    Goto T; Camargo CA; Hasegawa K
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2149-2155. PubMed ID: 27660432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating Fractional Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease (COPD) and Asthma-COPD Overlap (ACO): A Scoping Review.
    Mostafavi-Pour-Manshadi SM; Naderi N; Barrecheguren M; Dehghan A; Bourbeau J
    COPD; 2018; 15(4):377-391. PubMed ID: 30067401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional Exhaled Nitric Oxide Testing: Diagnostic Utility in Asthma, Chronic Obstructive Pulmonary Disease, or Asthma-chronic Obstructive Pulmonary Disease Overlap Syndrome.
    Miskoff JA; Dewan A; Chaudhri M
    Cureus; 2019 Jun; 11(6):e4864. PubMed ID: 31417809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional Exhaled Nitric Oxide as an Inflammatory Biomarker in Chronic Obstructive Pulmonary Disease (COPD) with or without Concurrent Diagnosis of Asthma: The Canadian Cohort Obstructive Lung Disease (CanCOLD).
    Mostafavi-Pour-Manshadi SM; Naderi N; Mancino P; Li PZ; Tan W; Bourbeau J
    COPD; 2020 Aug; 17(4):355-365. PubMed ID: 32584165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.